Archives of Disease in Childhood 2006;91:594-597
ORIGINAL ARTICLE
Complications associated with the bacille Calmette-Guérin vaccination in Ireland
Our Ladys Hospital for Sick Children, Dublin, Eire
Correspondence to:
Dr T Bolger
2 Valley Avenue, Druid Valley, Cabinteely, Dublin 18, Eire; turloughbolger{at}yahoo.co.uk
Introduction: BCG vaccination is currently recommended for all newborns in Ireland except where specifically contraindicated. This paper describes a marked increase in the number of referrals of patients with localised complications after vaccination to two Dublin paediatric hospitals. This increase coincided with the introduction of a new strain of BCG vaccine
![]() View larger version (92K): [in a new window] Figure 1 Severe suppurative adenopathy post-BCG vaccination. Consent was obtained for publication of this figure.
|
![]() View larger version (65K): [in a new window] Figure 2 Inoculation site abscess post-BCG vaccination. Consent was obtained for publication of this figure.
|
Methods: A population surveillance study was undertaken to determine the frequency and spectrum of complications associated with the new strain of BCG vaccine introduced in Ireland. Patients were identified though review of the infectious disease service case records and microbiology laboratory culture reports for the two year period from August 2002 to July 2004. Prospectively gathered data were supplemented by retrospective chart review. All infants who had inoculation site abscesses, suppurative adenopathy, or non-suppurative adenopathy with nodes
2 cm were included.
Results: Fifty eight patients presented a median of 13 weeks post-inoculation: 32 with suppurative adenitis, 17 with inoculation site abscess, three with both inoculation site abscess and suppurative adenitis, and six with non-suppurative adenopathy. The overall complication rate was estimated at 1/931 vaccinees with 1/1543 developing suppurative adenitis. Twenty six infants required surgery.
Discussion: This series illustrates the role of hospitals in sentinel surveillance and highlights the importance of having a well functioning and responsive system of adverse event reporting. These events raise a serious question as to the suitability of this vaccine strain for use in a national immunisation programme in a country where the prevalence of tuberculous disease is 10.4/100 000.
Keywords: BCG; abscess; adenitis; vaccination
Relevant Article
Read all eLetters![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Arch. Dis. Child. 2006 91: e1.
eLetters:
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.





